- CEO
- Qing Can Su
- Full Time Employees
- 8,200
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- Xiamen China
- IPO Date
- Nov 7, 2022
- Business
- Huaxia Eye Hospital Group Co., Ltd. is a China-based healthcare services provider specializing in comprehensive ophthalmic medical and optical care. Founded in 2004 and headquartered in Xiamen, Fujian Province, the company operates an extensive nationwide network of specialized eye hospitals and optometry centers across mainland China. Huaxia Eye Hospital Group delivers a full spectrum of clinical ophthalmology and vision health services, organized into core specialty segments including: refractive surgery, offering small incision lenticule extraction (SMILE), femtosecond-assisted laser in situ keratomileusis (FS-LASIK), and implantable collamer lens (ICL/TICL) surgeries for myopia, hyperopia, and astigmatism; cataract and presbyopia treatment, providing femtosecond laser-assisted cataract surgery, micro-incision phacoemulsification, and premium multifocal, trifocal, and extended depth of focus (EDOF) intraocular lens implantations; ocular fundus and vitreoretinal care, encompassing vitrectomy, laser photocoagulation, and anti-vascular endothelial growth factor (anti-VEGF) therapies for macular degeneration, diabetic retinopathy, and retinal detachment; optometry and pediatric ophthalmology, comprising medical refraction, vision training, strabismus and amblyopia correction, and the prescription and dispensing of orthokeratology (Ortho-K) lenses, defocus lenses, spectacles, and contact lenses; ocular surface and corneal disease management, covering corneal transplantation, keratoconus cross-linking, and intense pulsed light (IPL) therapies for dry eye syndrome; and glaucoma, oculoplastic, and orbital disease interventions, including minimally invasive glaucoma surgery (MIGS), trabeculectomy, and reconstructive ocular procedures. In addition to clinical procedures, the company sells ophthalmic pharmaceuticals, surgical consumables, and customized optical products. In recent strategic developments, Huaxia Eye Hospital Group has accelerated its nationwide footprint expansion through targeted equity acquisitions and consolidations of regional ophthalmic hospitals across multiple Chinese provinces. The company has also expanded its digital healthcare capabilities by implementing artificial intelligence-driven diagnostic imaging systems for rapid ocular disease screening, deployed next-generation femtosecond laser and premium lens technologies across its hospital network, and strengthened clinical research and residency partnerships with leading academic medical institutions.